2,3-dinor-thromboxane b2 has been researched along with salicylates in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fitzgerald, DJ; Keimowitz, RM; Mayo, G; Pulvermacher, G | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and salicylates
Article | Year |
---|---|
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
Topics: Administration, Cutaneous; Adult; Aspirin; Blood Platelets; Bradykinin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Middle Aged; Salicylates; Salicylic Acid; Thromboxane B2 | 1993 |